Poor quality of drugs has been blamed for undermining the fight against malaria. The group with the highest percentage of failed antimalarial medicine were the antifoliates(27 per cent) followed by artemisinin based monotherapies(24), quinine drugs(21), ACTs(17) and antibiotics(eight per cent). Text the word 'NEWS' to 22840The reported noted that the reason why patients seek a particular treatment for malaria are based on price, availability and efficacy. “If high quality medicines are supplied at an affordable price patients may find less reason to purchase cheaper, lower quality alternates,” the report read. “This trend may be due to ACTs being the recommended first line treatment for malaria infection in malaria endemic countries,” the report explained.

Source: Standard Digital April 26, 2018 07:30 UTC